Column Group’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.74M | Hold |
9,400,290
| – | – | 8.74% | 4 |
|
2025
Q1 | $5.36M | Hold |
9,400,290
| – | – | 12.12% | 3 |
|
2024
Q4 | $13.4M | Hold |
9,400,290
| – | – | 24.12% | 2 |
|
2024
Q3 | $18.1M | Hold |
9,400,290
| – | – | 26.08% | 2 |
|
2024
Q2 | $29.1M | Hold |
9,400,290
| – | – | 40.88% | 1 |
|
2024
Q1 | $49.2M | Hold |
9,400,290
| – | – | 30.62% | 1 |
|
2023
Q4 | $30.5M | Hold |
9,400,290
| – | – | 20.12% | 3 |
|
2023
Q3 | $24M | Hold |
9,400,290
| – | – | 15.92% | 3 |
|
2023
Q2 | $55.2M | Hold |
9,400,290
| – | – | 21.42% | 2 |
|
2023
Q1 | $26.8M | Hold |
9,400,290
| – | – | 9.69% | 4 |
|
2022
Q4 | $18.9M | Hold |
9,400,290
| – | – | 6.29% | 5 |
|
2022
Q3 | $27.3M | Hold |
9,400,290
| – | – | 6.03% | 4 |
|
2022
Q2 | $52.9M | Hold |
9,400,290
| – | – | 11.26% | 3 |
|
2022
Q1 | $111M | Hold |
9,400,290
| – | – | 20.53% | 2 |
|
2021
Q4 | $178M | Hold |
9,400,290
| – | – | 24.23% | 2 |
|
2021
Q3 | $194M | Buy |
+9,400,290
| New | +$194M | 22.08% | 2 |
|